02/10/2016
https://www.congress.gov...
"The cost. Companies develop drugs because, in the end, they are reporting to shareholders and they have to make a profit."
"There is just something, in terms of the FDA making these decisions for parents and patients, that we have to come to grips with."
"I want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like Matt to actually get a drug and have the 'Right to Try.'"
"I am sorry. Who are you to tell Matt that you are going to protect him from exploitation when he has no further hope?"